Telbivudine globe trial at year two: Efficacy, safety, and predictors of outcome in patients with chronic hepatitis B

被引：0
|
作者：
Han, Steven-Huy
Lai, Ching Lung
Gane, Edward J.
Liaw, Yun-Fan
Thongsawar, Satawat
Wang, Yuming
Chen, Yagang
Heathcote, E. Jenny
Rasenack, Jens
Bzowej, Natalie
Naoumov, Nikolai V.
Brown, Nathaniel A.
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A765 / A765
页数：1
相关论文
共 50 条
  • [31] Telbivudine (LdT) vs. lamivudine for chronic hepatitis B: First-year results from the international phase III globe trial
    Lai, CL
    Gane, E
    Liaw, YF
    Thongsawat, S
    Wang, YM
    Chen, YG
    Heathcote, EJ
    Rasenack, J
    Bzowej, N
    Naoumov, N
    Chao, G
    Constance, BF
    Brown, NA
    HEPATOLOGY, 2005, 42 (04) : 748A - 748A
  • [32] Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy
    Liu, M.
    Cai, H.
    Yi, W.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 65 - 70
  • [33] Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B
    He, Tianyu
    Bai, Yuqing
    Cai, Haodong
    Ou, Xiaojuan
    Liu, Min
    Yi, Wei
    Jia, Jidong
    HEPATOLOGY INTERNATIONAL, 2018, 12 (02) : 118 - 125
  • [34] Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B
    Tianyu He
    Yuqing Bai
    Haodong Cai
    Xiaojuan Ou
    Min Liu
    Wei Yi
    Jidong Jia
    Hepatology International, 2018, 12 : 118 - 125
  • [35] FIVE-YEAR OUTCOME OF TELBIVUDINE VERSUS ENTECAVIR IN TREATING HIGH VIRAL LOAD CHRONIC HEPATITIS B PATIENTS
    Pan, H. -Y.
    Ren, Z. -Z.
    Huang, H. -J.
    Zou, H.
    Tong, Y. -X.
    Yang, D. -H.
    Pan, H. -Y.
    Chen, M. -J.
    Wang, M. -S.
    Huang, Y. -C.
    Zhang, J. -J.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S590 - S591
  • [36] Durability of efficacy after telbivudine off-treatment in chronic hepatitis B patients
    Chen Da-biao
    Chen You-ming
    Liu Jing
    Xie Dong-ying
    Lu Cui-rong
    Huang Zhan-lian
    Zhu Rui-hua
    Gao Zhi-liang
    JOURNAL OF CLINICAL VIROLOGY, 2014, 59 (01) : 50 - 54
  • [37] Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience
    Tsai, M. -C.
    Chen, C. -H.
    Tseng, P. -L.
    Hung, C. -H.
    Chiu, K. -W.
    Wang, J. -H.
    Lu, S. -N.
    Lee, C. -M.
    Chang, K. -C.
    Yen, Y. -H.
    Lin, M. -T.
    Chou, Y. -P.
    Hu, T. -H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (01) : 95.e1 - 95.e7
  • [38] Telbivudine (LdT) compared to lamivudine for treatment of chronic hepatitis B: results from GLOBE, an international phase III trial
    Lai, Ching-Lung
    Gane, Edward
    Thongsawat, Satawat
    Wang, Yumin
    Heathcote, Jennifer
    Moon, Young-Myoung
    Chen, Yagang
    Lu, Wei-Lun
    Niu, Jungi
    Lim, Seng-Gee
    Hou, Jin-Lin
    Yin, You-Kuan
    Naoumov, Nikolai
    Bzowej, Natalie
    Chao, George
    Fielman, Barbara
    Brown, Nathaniel
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A129 - A130
  • [39] Telbivudine versus lamivudine in patients with chronic hepatitis B
    Lai, Ching-Lung
    Gane, Edward
    Liaw, Yun-Fan
    Hsu, Chao-Wei
    Thongsawat, Satawat
    Wang, Yuming
    Chen, Yagang
    Heathcote, E. Jenny
    Rasenack, Jens
    Bzowej, Natalie
    Naoumov, Nikolai V.
    Di Bisceglie, Adrian M.
    Zeuzem, Stefan
    Moon, Young Myoung
    Goodman, Zachary
    Chao, George
    Constance, Barbara Fielman
    Brown, Nathaniel A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (25): : 2576 - 2588
  • [40] Telbivudine versus Entecavir in Patients with Chronic Hepatitis B: 2-Year Results of a Head-To-Head Trial
    Huang, Jing
    Chen, Xiaoping
    Chen, Xuefu
    Chen, Re
    Chen, Wenli
    Ma, Xiaojun
    Luo, Xiaodan
    HEPATOLOGY, 2013, 58 : 681A - 681A
12345